ATE110280T1 - Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. - Google Patents

Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Info

Publication number
ATE110280T1
ATE110280T1 AT90909466T AT90909466T ATE110280T1 AT E110280 T1 ATE110280 T1 AT E110280T1 AT 90909466 T AT90909466 T AT 90909466T AT 90909466 T AT90909466 T AT 90909466T AT E110280 T1 ATE110280 T1 AT E110280T1
Authority
AT
Austria
Prior art keywords
encouraged
active substances
effective site
substances delivered
msh4
Prior art date
Application number
AT90909466T
Other languages
English (en)
Inventor
David Peter Page-Thomas
David Roy Bard
Clive Graham Knight
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898914527A external-priority patent/GB8914527D0/en
Priority claimed from GB909007469A external-priority patent/GB9007469D0/en
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Application granted granted Critical
Publication of ATE110280T1 publication Critical patent/ATE110280T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • C07K14/685Alpha-melanotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90909466T 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen. ATE110280T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898914527A GB8914527D0 (en) 1989-06-23 1989-06-23 Targetting agents
GB909007469A GB9007469D0 (en) 1990-04-03 1990-04-03 Targetting agents

Publications (1)

Publication Number Publication Date
ATE110280T1 true ATE110280T1 (de) 1994-09-15

Family

ID=26295539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909466T ATE110280T1 (de) 1989-06-23 1990-06-22 Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.

Country Status (9)

Country Link
EP (1) EP0478631B1 (de)
JP (1) JPH04506343A (de)
AT (1) ATE110280T1 (de)
AU (1) AU636365B2 (de)
DE (1) DE69011861T2 (de)
DK (1) DK0478631T3 (de)
ES (1) ES2057572T3 (de)
NZ (1) NZ234173A (de)
WO (1) WO1991000111A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003798A2 (en) * 1988-10-04 1990-04-19 Cancer Research Campaign Technology Limited Targetting agents
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
AU709012B2 (en) * 1994-11-17 1999-08-19 Amgen, Inc. Stable N-terminally linked DTPA:protein compositions and methods
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
US7575575B2 (en) 2005-03-18 2009-08-18 Ron Anthon Olsen Adjustable splint for osteosynthesis with modular components
US8123747B2 (en) 2007-08-16 2012-02-28 Nutek Orthopaedics, Inc. Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means
US7717916B2 (en) 2007-08-16 2010-05-18 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means
US8262657B2 (en) 2007-08-16 2012-09-11 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means and convergent bone pins
US8603435B2 (en) 2008-01-10 2013-12-10 Stc.Unm Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
KR100999044B1 (ko) 2008-03-26 2010-12-09 한국원자력연구원 킬레이트제 접합 α-MSH 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물

Also Published As

Publication number Publication date
WO1991000111A1 (en) 1991-01-10
EP0478631A1 (de) 1992-04-08
AU5839190A (en) 1991-01-17
AU636365B2 (en) 1993-04-29
EP0478631B1 (de) 1994-08-24
DE69011861T2 (de) 1995-02-16
JPH04506343A (ja) 1992-11-05
DK0478631T3 (da) 1995-04-10
NZ234173A (en) 1993-10-26
DE69011861D1 (de) 1994-09-29
ES2057572T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
DE68912302D1 (de) Härtendes material für medizinischen und dentalen gebrauch.
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ATE110280T1 (de) Zum wirkort hingeführte und dort angereicherte aktivsubstanzen.
DE69717788D1 (de) Komprimierte speicherung eines patientenberichts und wiederaufbau des kompletten textes in implantierbare medizinische vorrichtungen
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
EP0693928A4 (de) Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
ATE106898T1 (de) Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
BG103439A (bg) Подобрения в или във връзка с диагностични/лечебни средства
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
FI920664A7 (fi) Menetelmä hammas- ja sairaanhoidon alalla käytettävien restauraatioide n, proteesien tai vastaavien valmistamiseksi
BR9403783A (pt) Uso de uma composição cosmética
FI972286A7 (fi) Uudella tavalla substituoituja DTPA-johdoksia, niiden metallikomplekse ja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita ja niiden k äyttö diagnosoinnissa ja terapiassa
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
FR2705558B1 (fr) Prothèse de reconstruction de hanche et l'appareil de pose.
ATE120091T1 (de) Vip-konjugate und deren aktive fragmente mit hydrophoben anteilen und topische zuberetungen zur verwendung in der behandlung männlicher impotenz.
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DE68929261D1 (de) Aushärtender Werkstoff für ärztlichen und zahnärztlichen Gebrauch
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
HU902004D0 (en) New trombolitic preparations
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
IT1241681B (it) Impianto ortopedico in particolare per l'impiego per la riparazione e/o ricostruzione chirurgica di giunzioni del corpo umano

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee